TRIAMCINOLONE ACETONIDE
| Brand name | TRIESENCE |
|---|---|
| Active ingredient | TRIAMCINOLONE ACETONIDE |
| Strength | 40MG/ML (40MG/ML) |
| Dosage form | INJECTABLE |
| Route | INTRAVITREAL |
| Modality | Small molecule |
| FDA approval | November 2007 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8128960 | December 2029 | product |
| 8211880 | March 2029 | use U-1257 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.